Institutional investors lightened up their holdings of BLRX shares during the quarter ended -- as they sold a net -- shares. Additionally, the 13.24% of shares outstanding that remains in their hands is below average for companies in the Pharmaceuticals: Other industry and highlights that this company is not an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Sold 5.0 Thousand shares of BioLine RX Ltd